Immunoblotting analysis indicated that ASA treatment resulted in increased expressions of BimEL in both WCs and SCs of ESCC cell lines, KYSE180 and KYSE410. This evidence concerns the gene BCL2L11 and esophageal squamous cell carcinoma.